|
|
Other links at Articles > Business of Medicine |
| 5. |
Novartis Cancer Drug Wins U.S. Priority Review
|
|
|
An investigational drug from Swiss drugmaker Novartis AG has been granted priority review in the United States as a treatment for advanced kidney cancer. Reuters Health Information
|
|
|